SectorBiotechnology Ⅲ
Established Date24/03/2006
Listing Date22/10/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees46
Fiscal Year Ends31/12
Security TypeCommon stock
Office address345 Park Avenue South, 3rd Floor, New York, NY 10010
BusinessAdvances transformative therapies for cancer and rare diseases.
IntroductionProtara Therapeutics, Inc., was originally incorporated in Delaware on March 24, 2006. The company is a clinical-stage biopharmaceutical company based in New York City that advances transformative therapies for the treatment of cancer and rare diseases. The company's product portfolio includes two development projects utilizing TARA-002, an investigational cell therapy based on the broad immune-enhancing agent OK-432, which was originally granted marketing authorization by the Ministry of Health and Welfare of Japan as an immune-enhancing cancer treatment agent.
